Qol Holdings
3034.TTSE PRIMERetail Trade
Filed as Qol Holdings Co., Ltd. (2022-06–2026-06)
Financials · Consolidated
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥290.8bn | ¥264.0bn | ¥180.1bn | ¥170.0bn | ¥166.2bn | ¥161.8bn |
| Operating income | ¥14.8bn | ¥13.5bn | ¥8.3bn | ¥9.5bn | ¥9.9bn | ¥7.4bn |
| Ordinary income | ¥14.9bn | ¥13.8bn | ¥9.3bn | ¥10.1bn | ¥10.1bn | ¥7.4bn |
| Net income (owners) | ¥7.4bn | ¥5.2bn | ¥4.9bn | ¥5.7bn | ¥5.5bn | ¥3.4bn |
| Total assets | ¥158.1bn | ¥159.7bn | ¥117.8bn | ¥101.9bn | ¥96.0bn | ¥100.6bn |
| Net assets / equity | ¥59.8bn | ¥62.1bn | ¥52.8bn | ¥48.9bn | ¥43.9bn | ¥41.8bn |
| Operating cash flow | ¥18.7bn | ¥12.6bn | ¥13.5bn | ¥11.7bn | ¥10.1bn | ¥12.9bn |
| EPS (basic) | ¥197.35 | ¥137.97 | ¥131.11 | ¥152.96 | ¥149.51 | ¥89.55 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 5
| Period | Form | Figures |
|---|---|---|
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 49 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 73 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 47 figures · EDINET |
| 2022-04-01 → 2023-03-31 | AnnualAmended | 202 figures · EDINET |
| 2022-04-01 → 2023-03-31 | Annual | 202 figures · EDINET |
22 more reports are still being processed.
Segments · FY ended 2026-03
| Segment | External sales | Profit |
|---|---|---|
| BPO | ¥14.3bn | ¥1.9bn |
| Health Insurance Pharmacy | ¥177.5bn | ¥9.7bn |
| Pharmaceutical Business | ¥99.0bn | ¥7.0bn |
| Adjustments & eliminations | — | −¥3.8bn |
| Total | ¥290.8bn | ¥18.6bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.